Loading…

Loading grant details…

Completed HORIZON European Commission

A natural breast for cancer survivors: resorbable implant supporting tissue regeneration

€3.57M EUR

Funder European Commission
Recipient Organization Tensive Srl
Country Italy
Start Date Mar 01, 2023
End Date Feb 28, 2025
Duration 730 days
Number of Grantees 1
Roles Coordinator
Data Source European Commission
Grant ID 190163787
Grant Description

Of the 3 million women undergoing breast cancer resection every year, only a few opt for breast reconstruction due to pain, concerns about follow-up procedures and the lack of options. For lumpectomy patients traditional implants cannot be used, with only ~20-30% of lumpectomies being reconstructed.

Autologous tissue transfer requires multiple painful interventions to reconstruct large volumes and obtain satisfactory results.

Furthermore, both implants and autologous solutions require multiple follow-up surgeries, increasing costs and pain for the patients.

REGENERA will be a unique solution for lumpectomy patients: a resorbable implant designed to restore a natural breast through tissue self-regeneration.

It is a cell-free porous scaffold made of resorbable biocompatible poly(urethane-ester-ether) with a biomimetic architecture.

It is designed to avoid follow-up surgeries and eliminate the risks associated with silicone and saline implants (rupture, leakage, ALCL) and fat grafting.

All Grantees

Tensive Srl

Advertisement
Discover thousands of grant opportunities
Advertisement
Browse Grants on GrantFunds
Interested in applying for this grant?

Complete our application form to express your interest and we'll guide you through the process.

Apply for This Grant